Not exact matches
For a
cancer with very high genetic
diversity (like AML) however, the unintended effect of treatment is often to select for the most aggressive, resistant
cells, clearing away their competitors and furnishing them with all the resources they need to flourish.
Generally speaking, the seriousness of a given
cancer diagnosis may be linked with genetic
diversity in cancerous
cells.
A new method to take the DNA fingerprint of individual
cancer cells is uncovering the true extent of
cancer's genetic
diversity, new research reveals.
«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the
diversity of T
cells within the tumor environment and their influence on ovarian
cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.
The results validated a previous group's discovery that measurement of the genetic
diversity between Barrett's
cells in any given lesion is a good predictor of which patients are at high risk of developing
cancer.
The team has already revealed a huge amount of genetic
diversity between
cancer cells taken from different sites within each man's prostate.
Professor Steven Bova, based at the University of Tampere, Finland, and head of ICGC prostate
cancer UK metastatic studies, said: «The
diversity we've found suggests multiple biopsies might be needed to identify the «trunk» of the
cancer's tree of mutations — we need treatments that target these core weaknesses to destroy all
cancer cells in a clean sweep, rather than trimming the branches.
This unusually thorough list helped the researchers tease out subtle differences between generations of same
cancer cells treated with chemotherapy and chart how the
cancer cell community increased
diversity among its members through RNA.
In this video Dr. Odunsi discusses a new study that found that higher T -
cell diversity in ovarian
cancer is associated with poor overall survival.
Now, scientists at the Salk Institute have uncovered details about how
cancer is able to become drug resistant over time, a phenomenon that occurs because
cancer cells within the same tumor aren't identical — the
cells have slight genetic variation, or
diversity.
These new findings may potentially point to a «switch» to turn off this
diversity — and thereby drug resistance — in
cancer cells.
To uncover how groups of
cancer cells achieve functional
diversity (through RNA) to survive chemotherapy, Lopez - Diaz dosed dishes of human pre-
cancer and metastatic breast
cancer cells with the
cancer drug paclitaxel for a week and then removed the drug for a few weeks, mimicking the treatment cycle for a
cancer patient.
The most rigorous genetic sequencing ever carried out on a single tumor reveals far greater genetic
diversity among
cancer cells than anticipated.
So despite their
diversity, all
cancer cells share one critical thing in common: they are absolutely dependent for their survival on their ability to hijack telomerase (or, less frequently, ALT).
Overall the goal is to eat a rainbow of foods so we are getting a
diversity of antioxidants to protect our
cells from damage and help prevent
cancer.
Other heritable conditions that are related to loss of genetic
diversity and inbreeding include cataract, various heart valve defects including pulmonic stenosis, hydrocephalus, cysteine urolithiasis, and hiatal hernias; immunologic disorders that include a propensity for severe demodectic mange indicative of immunodeficiency, allergies associated with atopic dermatitis and ear infections, and autoimmune diseases such as hypothyroidism; and
cancers including glioblastoma, mast
cell sarcoma and lymphoma [15, 16].